Do treatment emergent adverse events correlate with antiseizure medication drug load and summed medications levels ?

Details

Ressource 1 Under indefinite embargo.
UNIL restricted access
State: Public
Version: After imprimatur
License: Not specified
Serval ID
serval:BIB_B5D0DC8A2F69
Type
A Master's thesis.
Publication sub-type
Master (thesis) (master)
Collection
Publications
Institution
Title
Do treatment emergent adverse events correlate with antiseizure medication drug load and summed medications levels ?
Author(s)
PRETAT T.
Director(s)
NOVY J.
Institution details
Université de Lausanne, Faculté de biologie et médecine
Publication state
Accepted
Issued date
2021
Language
english
Number of pages
7
Abstract
Associated treatment emergent adverse events (TEAE) correlating with antiseizure medication (ASM) drug load is a controversial topic. Previous studies used daily defined dosage (DDD) to measure drug load. We aim to assess if drug corrected for weight as well as ASM plasma levels were associated with TEAE.
We analysed clinical visits of a trial on therapeutic drug monitoring. TEAE, treatment and its changes as well as ASM plasma levels were recorded at each visit. Each medication level was stratified according to its position in relation to its proposed reference range (below, in lower half, upper half or above).
We analyzed 424 visits (151 participants). TEAE were reported at 84 (19.7%) visits. There was no significant difference when comparing visits with TEAE with those without TEAE in terms of ASM drug load (calculated with DDD), corrected for body weight, their changes since the last visit, as well as summed plasma levels compared to reference ranges.
Drug load seems not to be a major determinant of TEAE as recording during routine visits, even when accounting thoroughly for the patient’s exposure to the treatment. The use of questionnaires and neuropsychometric tests are likely to assess more accurately the potential consequences of drug loads.
Keywords
Antiseizure drug, antiepileptic drug, tolerability, treatment discontinuation
Create date
07/09/2022 13:27
Last modification date
26/09/2023 5:58
Usage data